Skip to main navigation Skip to search Skip to main content

Erratum: Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy: A position statement from the AEPC Working Group on Basic Science, Genetics and Myocardial Disease and the AEPC Working Group on Cardiac Dysrhythmias and Electrophysiology (Cardiology in the Young (2023) 33:5 (681–698) DOI: 10.1017/S1047951123000872)

  • Juan Pablo Kaski
  • , Janneke A. E. Kammeraad
  • , Nico A. Blom
  • , Juha-Matti Happonen
  • , Jan Janousek
  • , Sabine Klaassen
  • , Giuseppe Limongelli
  • , Ingegerd Östman-Smith
  • , Georgia Sarquella Brugada
  • , Lidia Ziolkowska

Research output: Contribution to journalComment/Letter to the editorAcademic

15 Downloads (Pure)

Abstract

The publisher apologises that the final three pages of this article were missing in its initial publication. This article has been updated to include the pages.

Original languageEnglish
Pages (from-to)469
Number of pages1
JournalCardiology in the young
Volume34
Issue number2
DOIs
Publication statusPublished - 22 Feb 2024

Fingerprint

Dive into the research topics of 'Erratum: Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy: A position statement from the AEPC Working Group on Basic Science, Genetics and Myocardial Disease and the AEPC Working Group on Cardiac Dysrhythmias and Electrophysiology (Cardiology in the Young (2023) 33:5 (681–698) DOI: 10.1017/S1047951123000872)'. Together they form a unique fingerprint.

Cite this